Home LiteratureArticle Details
PMID: 11698140 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment.

Neuroscience letters ·Vol. 314 ·No. 1-2 ·2001-11-13 ·Pages 33-6

Sjögren M, Gisslén M, Vanmechelen E, Blennow K

Abstract

CSF-A beta 42 may be a marker of Alzheimer's disease (AD). A decreased level of CSF-A beta 42 is consistently found in AD and has been suggested to be related to the deposition of amyloid plaques in the brain. However, low CSF-A beta 42 levels have also been found in disorders devoid of plaques, for instance Creutzfeldt-Jakob disease. To examine if the level of A beta 42 in CSF is related to inflammatory processes, we studied CSF-A beta 42 levels in eight patients with acute purulent bacterial meningitis, 10 patients with acute viral meningitis and 18 age-matched controls. In acute purulent bacterial meningitis, the CSF-A beta 42 level was markedly reduced (28% of that in controls, P<0.0001), whereas no change was found in viral meningitis. After successful treatment of bacterial meningitis, the CSF-A beta 42 level increased (P<0.05 compared to baseline) and did no longer differ from that in controls (ns). The decrease could not be explained by interference with high protein levels, since addition of increasing volumes of serum did not influence the CSF-A beta 42 levels. Our findings suggest that the reduction in CSF-A beta 42 found in bacterial meningitis is not a direct consequence of the inflammatory process. The cause may be disturbance of the clearance of A beta 42 from the brain.

MeSH Terms
Acute Disease Adult Albumins/cerebrospinal fluid Amyloid beta-Peptides/cerebrospinal fluid Anti-Bacterial Agents/therapeutic use Biomarkers/cerebrospinal fluid Brain/metabolism,microbiology,physiopathology Haemophilus influenzae/metabolism Humans Klebsiella pneumoniae/metabolism Meningitis, Bacterial/cerebrospinal fluid,diagnosis,drug therapy Meningitis, Viral/cerebrospinal fluid Middle Aged Peptide Fragments/cerebrospinal fluid Streptococcus oralis/metabolism Streptococcus pneumoniae/metabolism Treatment Outcome
Chemicals
Albumins Amyloid beta-Peptides Anti-Bacterial Agents Biomarkers Peptide Fragments amyloid beta-protein (1-42)
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sjögren M
Institute of Clinical Neuroscience, Göteborg University, Sahlgrenska University Hospital, Mölndal, SE 431 80 Mölndal, Sweden. magnus.sjogren@medfak.gu.se
Gisslén M
Vanmechelen E
Blennow K
Article Info
Journal
Neuroscience letters
Abbr.
Neurosci Lett
ISSN
0304-3940
Published
2001-11-13
Pages
33-6
Language
English
Region
Ireland
NLM ID
7600130
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com